openPR Logo
Press release

Acute Kidney Injury Treatment Market Size, Share and Global Industry Analysis Report 2024 to 2029

04-01-2025 01:22 PM CET | Health & Medicine

Press release from: Medi-Tech Insights

Acute Kidney Injury Treatment Market Size, Share and Global

The acute kidney injury (AKI) treatment market is experiencing steady growth, with a CAGR projected at approximately 8% during the forecast period. The market is driven by several key factors, including the increasing incidences of AKI due to chronic diseases like diabetes and hypertension, the rising geriatric population, and the growing number of surgeries and hospitalizations. Additionally, the expansion of healthcare infrastructure and the increasing availability of advanced diagnostic technologies contribute to market growth. However, high treatment costs and limited access to specialized healthcare facilities in certain regions act as major restraints.

Acute kidney injury (AKI) refers to the sudden decline in kidney function, often caused by reduced blood flow, direct damage to the kidneys, or blockages. This condition causes a buildup of waste products in the blood and disrupts the balance of fluids, electrolytes, and acid-base levels in the body. Treatment for AKI generally involves addressing the underlying cause, managing symptoms, and supporting kidney recovery through interventions like dialysis or medication. Early detection and prompt treatment are critical to improving outcomes and preventing long-term damage.

Explore market trends, size, share and growth report - request a sample copy: https://meditechinsights.com/acute-kidney-injury-treatment-market/request-sample/

Significant Factor Driving Demand: Aging Population and Increased Hospitalizations

A crucial factor driving the demand in the acute kidney injury treatment market is the growing aging population. Older adults are more prone to developing AKI due to age-related declines in kidney function, as well as their higher susceptibility to chronic diseases such as cardiovascular conditions, diabetes, and hypertension. Additionally, this demographic group undergoes more frequent surgeries and hospitalizations, which are known risk factors for AKI, particularly when involving complex procedures like heart surgeries and organ transplants. According to the United Nations, the global aged population will nearly double by 2050, significantly raising the burden of chronic diseases and driving the demand for specialized treatment options. The healthcare industry is increasingly focused on early intervention and managing the heightened AKI risk among elderly patients, further boosting the need for effective therapies.

Emerging Trend: Biomarkers for Early Detection of AKI

An emerging trend enhancing the AKI treatment market is the development of biomarkers for early detection and diagnosis. Traditional diagnostic methods, such as serum creatinine levels, are often unreliable in identifying AKI at its onset, leading to delayed treatment and poorer patient outcomes. Biomarkers like Neutrophil Gelatinase-Associated Lipocalin (NGAL), Cystatin C, and Kidney Injury Molecule-1 (KIM-1) are gaining attention for their potential to detect AKI earlier and more accurately. While NGAL and Cystatin C are starting to see use in some clinical settings for early identification of AKI, KIM-1 is still primarily in research and clinical trial stages. The integration of these biomarkers into clinical practice is expected to enhance patient outcomes by allowing for timely interventions and more effective management of kidney health, reflecting a broader shift toward precision medicine and personalized healthcare in AKI treatment.

Explore the latest trends and deep insights in just one click: https://meditechinsights.com/acute-kidney-injury-treatment-market/

Competitive Landscape Analysis

The global acute kidney injury treatment market is marked by the presence of established and emerging market players such as AM-Pharma; Astellas Pharma Inc.; Asahi Kasei Medical Co. Ltd.; Baxter Corporation; Novartis, Pfizer Inc.; Merck & Co.; NIPRO Medical; NIKKISO; Fresenius Medical Care AG & Co. KGaA; among others. Some of the key strategies adopted by market players include product innovation and development, strategic partnerships and collaborations, and geographic expansion.

Find more related report:

Urology and Pelvic Health Market: https://meditechinsights.com/urology-and-pelvic-health-market/

Urology Ultrasound Devices Market: https://meditechinsights.com/urology-ultrasound-devices-market/

Urology Imaging Systems Market: https://meditechinsights.com/urology-imaging-systems-market/

Global Dialysis Market Size & Trends Report: https://meditechinsights.com/dialysis-market/

Contact:

Ruta Halde
Associate, Medi-Tech Insights
Phone: +32 498 86 80 79
Email: info@meditechinsights.com
Website: https://meditechinsights.com/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Kidney Injury Treatment Market Size, Share and Global Industry Analysis Report 2024 to 2029 here

News-ID: 3948608 • Views:

More Releases from Medi-Tech Insights

Sterilization Equipment Market Shows Strong Investment Potential with 7-9% CAGR Forecast by 2029
Sterilization Equipment Market Shows Strong Investment Potential with 7-9% CAGR …
The global sterilization equipment market is set to experience significant growth, with an expected CAGR of 7-9% over the next 5 years. This growth is driven by increasing demand for sterilization in healthcare facilities, stringent infection control regulations, rising surgical procedures, necessity to curb hospital-acquired infections (HAIs), and advancements in sterilization technologies. Sterilization equipment plays a critical role in ensuring the safety and hygiene of medical instruments, devices, and environments. These
Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tech Insights
Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tec …
The global biologics market is set to witness a growth rate of 10-12% in the next 5 years. Rising prevalence of chronic diseases; continued advancements in biotechnology; growing investment in biopharmaceutical R&D; and growing strategic partnerships between biotech firms & larger pharmaceutical companies are some of the key factors driving the biologics market. Biologics are a class of medications derived from living organisms, including proteins, sugars, and nucleic acids among others.
Telemedicine Market to Grow at 16-18% CAGR By 2029, Fueled by Tech Advancements and Demand for Virtual Care
Telemedicine Market to Grow at 16-18% CAGR By 2029, Fueled by Tech Advancements …
The global telemedicine market is set to witness a robust growth rate of 16-18% over the next five years. This growth is driven by the increasing adoption of digital healthcare solutions, a rise in chronic disease prevalence, an aging population demanding more accessible care, technological advancements in telehealth platforms, growing government support, and the shift toward remote patient monitoring and virtual care solutions. Telemedicine refers to the remote diagnosis, treatment, and
High Flow Oxygen Therapy Market Set to Grow at 7% CAGR by 2029 Driven by Rising Respiratory Cases and Technological Advancements
High Flow Oxygen Therapy Market Set to Grow at 7% CAGR by 2029 Driven by Rising …
The high flow oxygen therapy (HFOT) market is growing at a projected compound annual growth rate (CAGR) of around 7% in the forecast period. Key drivers include the rising prevalence of respiratory diseases such as COPD, pneumonia, and acute respiratory failure, along with increased adoption of non-invasive treatments. Technological advancements in HFOT devices and the growing elderly population further support market growth. However, high device costs and limited reimbursement in

All 5 Releases


More Releases for AKI

Continuous Renal Replacement Therapy Market to Reach USD 3.5 Billion by 2035, Dr …
The global Continuous Renal Replacement Therapy (CRRT) Market is valued at USD 1.6 billion in 2025 and projected to reach USD 3.5 billion by 2035, expanding at a CAGR of 8.2%. Growth is fueled by the rising incidence of acute kidney injury (AKI) among critically ill patients, technological advances in dialysis machines, and the integration of AI-enabled CRRT systems that optimize treatment delivery. MarketGenics identifies CRRT as a cornerstone of intensive
Acute Kidney Injury AKI Equipment Market Size & Share Analysis - Growth Trends & …
Market Overview and Report Coverage Acute Kidney Injury (AKI) Equipment is a medical device used for the management and treatment of acute kidney injury, a sudden and rapid decline in kidney function. This equipment includes blood purification machines, dialysis machines, and other renal replacement therapy devices. The current outlook of the Acute Kidney Injury Equipment Market is promising, with a steady growth rate expected in the coming years. The market is driven
Acute Kidney Injury (AKI) Equipment Market | B.Braun, Baxter, JMS, Medtronic (Be …
The global acute kidney injury (aki) equipment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the acute kidney injury (aki) equipment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the
Acute Kidney Injury (AKI) Disease Treatment Market Size, Growth, In-depth Analys …
The Acute Kidney Injury (AKI) Disease Treatment Market is expected to grow at a CAGR of 2.07% to reach a market size worth US$34.596 billion by 2027. The prime factors propelling the growth of the acute kidney injury (AKI) disease treatment market are the growing elderly population raising the demand for acute kidney disease treatment. As per the report, the acute kidney injury (AKI) disease treatment market is expected to grow steadily
Acute Kidney Injury (AKI) Disease Treatment Market Size and Forecast US$31.600 b …
Acute kidney failure can be deadly and requires serious therapy. Nonetheless, intense kidney disappointment might be reversible. On the off chance that you're generally healthy, you might recuperate ordinary or almost typical kidney function. The Global Acute Kidney Injury (AKI) Disease Treatment market was valued at US$29.612 billion in 2022 and is expected to grow at a CAGR of +1% over the forecast period to reach a market size of US$31.600
Acute Kidney Injury (AKI) Equipment Market global outlook and forecast 2021 -202 …
The Global Acute Kidney Injury (AKI) Equipment Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Acute Kidney Injury (AKI) Equipment makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and